141 related articles for article (PubMed ID: 19011337)
41. [Trial of "Huber Plus" in outpatients with chemotherapy by blood port system].
Matsumura N; Tazumi K; Kouji K; Kondo M; Mizuki M
Gan To Kagaku Ryoho; 2008 Mar; 35(3):539-41. PubMed ID: 18347413
[TBL] [Abstract][Full Text] [Related]
42. Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations.
Ureña-Tavera A; Zamora-Verduga M; Madrigal-Burgaleta R; Angel-Pereira D; Berges-Gimeno MP; Alvarez-Cuesta E
J Allergy Clin Immunol; 2015 Apr; 135(4):1066-1067. PubMed ID: 25457996
[No Abstract] [Full Text] [Related]
43. [A case of recurrent colon cancer developed thrombosis in superior mesenteric vein after chemotherapy].
Furuyama H; Fuji H; Okumura S; Nishigori T; Kadokawa Y; Kondo M; Machimoto T; Asao Y; Yoshimura T
Gan To Kagaku Ryoho; 2013 May; 40(5):659-61. PubMed ID: 23863595
[TBL] [Abstract][Full Text] [Related]
44. [Colorectal carcinoma--primary treatment in case of advanced metastization].
Arnold D; Siewczynski R; Kubicka S; Hacker U; Schmoll HJ
Onkologie; 2008; 31 Suppl 5():3-8. PubMed ID: 19033697
[TBL] [Abstract][Full Text] [Related]
45. Interstitial lung disease associated with FOLFOX chemotherapy.
Lim JH; Kim H; Choi WG; Lee MH
J Cancer Res Ther; 2010; 6(4):546-8. PubMed ID: 21358098
[TBL] [Abstract][Full Text] [Related]
46. Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.
Cao W; Yang W; Lou G; Jiang J; Geng M; Xi W; Li H; Ma T; Jin Y
Anticancer Drugs; 2009 Apr; 20(4):287-93. PubMed ID: 19177020
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy and safety of modified FOLFOX6 regimen in aged patients with nonresectable colorectal cancer].
Ishiguro T; Ishibashi K; Okada N; Kuwabara K; Miyazaki T; Yokoyama M; Matsuki M; Sano M; Inoue N; Ishida H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2286-8. PubMed ID: 19106598
[TBL] [Abstract][Full Text] [Related]
48. Allergic reactions to oxaliplatin in a single institute in Japan.
Ichikawa Y; Goto A; Hirokawa S; Kijima M; Ishikawa T; Chishima T; Suwa H; Yamamoto H; Yamagishi S; Osada S; Ota M; Fujii S
Jpn J Clin Oncol; 2009 Sep; 39(9):616-20. PubMed ID: 19556337
[TBL] [Abstract][Full Text] [Related]
49. [Our outpatient cases for home anti-cancer chemotherapy using a CV port and a portable pump system].
Midorikawa Y; Nakachi T; Kasuga T
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():264-6. PubMed ID: 17469355
[TBL] [Abstract][Full Text] [Related]
50. [Drug information brochure for patients undergoing FOLFOX 4 chemotherapy based on survey of adverse reactions].
Imada H; Kawakami K; Hiraoka T; Higuchi S; Takahashi G; Aoyama T; Shinozaki E; Suenaga M; Matsuzaka S; Hama T
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1425-30. PubMed ID: 17876140
[TBL] [Abstract][Full Text] [Related]
51. [A case report of a patient with advanced rectal cancer who was administered chemotherapy in collaboration with a clinical pathway and visiting nursing care].
Iwata S; Imai S; Mochiduki H; Watanabe K; Imazeki M; Ueno M; Kaneko J; Komatsu Y; Taguchi Y; Watanabe Y; Hirata K; Suzuki C
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():361-3. PubMed ID: 17469387
[TBL] [Abstract][Full Text] [Related]
52. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab.
Ozen A; Cicin I; Sezer A; Uzunoglu S; Saynak M; Genchellac H; Karagol H
J Cancer Res Ther; 2009; 5(2):130-2. PubMed ID: 19542672
[TBL] [Abstract][Full Text] [Related]
53. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
[TBL] [Abstract][Full Text] [Related]
54. [Long-Term Successful Management of Recurrent Rectal Cancer in the Predialysis State with FOLFIRI Chemotherapy].
Koike N; Takeuchi T; Fujii T; Ohshima Y; Arita S; Isaka N; Shinozaki E
Gan To Kagaku Ryoho; 2015 Nov; 42(11):1427-30. PubMed ID: 26602405
[TBL] [Abstract][Full Text] [Related]
55. [A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective].
Suzuki N; Suzuki S; Tominaga K; Hoshino M; Naruse H; Fukushima M; Murakami M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2267-9. PubMed ID: 23268045
[TBL] [Abstract][Full Text] [Related]
56. Multicenter phase II study of FOLFOX for metastatic colorectal cancer (mCRC) in Japan; SWIFT-1 and 2 study.
Nagata N; Kondo K; Kato T; Shibata Y; Okuyama Y; Ikenaga M; Tanemura H; Oba K; Nakao A; Sakamoto J; Mishima H
Hepatogastroenterology; 2009; 56(94-95):1346-53. PubMed ID: 19950789
[TBL] [Abstract][Full Text] [Related]
57. [Present status of home therapy cancer patients using an infusor].
Tsuji Y; Tsushima T; Tanaka S; Mizushima T; Tamura F; Chiba H; Honda K; Makino K; Ohura K; Sumiyoshi T; Yoshizaki N; Kondo H
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():260-3. PubMed ID: 17469354
[TBL] [Abstract][Full Text] [Related]
58. High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin.
Magagnoli M; Masci G; Castagna L; Bramanti S; Morenghi E; Carnaghi C; Santoro A
Br J Haematol; 2005 Jun; 129(5):709-10. PubMed ID: 15916696
[No Abstract] [Full Text] [Related]
59. [A patient with recurrent sigmoid colon cancer in whom pleural effusion and ascites resolved after FOLFOX 4 therapy].
Akamatsu M; Tsuji Y; Nakata W; Ohmae T; Ohata K; Matsubara S; Katamoto T
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2305-7. PubMed ID: 18079636
[TBL] [Abstract][Full Text] [Related]
60. [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].
Fujiwara Y; Naomoto Y; Tanabe S; Sakurama K; Noma K; Nishikawa T; Motoki T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Tanaka N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):655-7. PubMed ID: 19381042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
